Pharmacy In China News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharmacy in china. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharmacy In China Today - Breaking & Trending Today

Government Issues Operational Guidelines For Production Linked Incentive Scheme Of Pharmaceuticals


Government has issued Operational guidelines for Production Linked Incentive Scheme of Pharmaceuticals. The Department of Pharmaceuticals notified the Production Linked Incentive (PLI) Scheme for Pharmaceuticals on 3rd March, 2021. The approved outlay of the scheme is Rs 15000 crore. The scheme envisages to create global champions out of India who have the potential to grow in size and scale using cutting edge technology and thereby penetrate the global value chains. Based on a series of consultations with pharmaceutical industry and stakeholders in the Government, the operational guidelines for the scheme have been prepared and issued on 1st June. The scheme is now open to applications from the industry. ....

Department Of Pharmaceuticals , Production Linked Incentive Scheme Of Pharmaceuticals , Production Linked Incentive Scheme , Production Linked Incentive , Global Manufacturing Revenue , Capital Market , Pharmaceuticals Policy , Pharmaceutical Industry In China , Pharmacy In China , Science And Technology In The Peoples Republic Of China , Ministry Of Chemicals And Fertilizers , Raft Production Linked Incentive Pli , Active Pharmaceutical , துறை ஆஃப் மருந்துகள் , ப்ரொடக்ஶந் இணைக்கப்பட்டுள்ளது ஊக்கத்தொகை திட்டம் , ப்ரொடக்ஶந் இணைக்கப்பட்டுள்ளது ஊக்கத்தொகை , உலகளாவிய உற்பத்தி வருவாய் , மூலதனம் சந்தை , மருந்துகள் பாலிஸீ ,

Aarti Drugs' unit gets approval under pharma PLI scheme


Aarti Speciality Chemicals, a wholly-owned subsidiary of Aarti Drugs has received an approval accorded under Production Linked Incentive (PLI) scheme for pharmaceutical sector.
Government of India s Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in Fermentation based - at least 90% and Two in the Chemical Synthesis based - at least 70%) with a total outlay of Rs 6,940 crore.
The objective of the scheme is achieving self-reliance and reducing import dependence in these critical Key Starting Materials (KSMs)/ Drug Intermediates/ Active Pharmaceutical Ingredients (APIs) in the country. The tenure of the scheme is from FY21 to FY30. ....

Adhish Patil , Government Of India Department Pharmaceuticals , Ministry Of Chemicals , Aarti Speciality Chemicals , Aarti Drugs , Production Linked Incentive , Chemical Synthesis , Key Starting Materials , Active Pharmaceutical Ingredients , Speciality Chemicals , Target Segment , Key Chemical Synthesis Based , Drug Intermediates , Chief Financial Officer , Pharma Intermediates , Capital Market , Pharmaceutical Industry In China , Pharmaceuticals Policy , Pharmacy In China , Science And Technology In The Peoples Republic Of China , Chemical Substance , Physical Sciences , Natural Sciences , Companies Based In , அரசு ஆஃப் இந்தியா துறை மருந்துகள் , அமைச்சகம் ஆஃப் இரசாயனங்கள் ,

Pharma stocks rally after cabinet approves PLI scheme


Shares of eight pharmaceutical companies rose by 0.5% to 3.4% after the cabinet approved Production Linked Incentive (PLI) scheme for pharmaceuticals segment.Hikal (up 3.46%), Neuland Laboratories (up 3.08%), IPCA Laboratories (up 2.85%), Alkem Laboratories (up 1.43%), Torrent Pharmaceutical (up 1.09%), Biocon (up 0.6%), Cadila Healthcare (up 0.58%) and Aurobindo Pharma (up 0.52%) were top gainers in pharmaceutical space.
The Union Cabinet on Wednesday approved Production Linked Incentive (PLI) scheme for pharmaceuticals over a period of Financial Year 2020-21 to 2028-29.
The scheme will benefit domestic manufacturers, help in creating employment and is expected to contribute to the availability of wider range of affordable medicines for consumers. The scheme is also expected to bring in investment of Rs 15,000 crore in the pharmaceutical sector. ....

Aurobindo Pharma , Union Cabinet On , Production Linked Incentive , Neuland Laboratories , Alkem Laboratories , Torrent Pharmaceutical , Cadila Healthcare , Union Cabinet , Financial Year , Diagnostic Devices , Capital Market , Health Sciences , Health Care , Pharmaceuticals Policy , Pharmaceutical Industry In China , Pharmacy In China , Science And Technology In The Peoples Republic Of China , Pharmaceutical Industry , Pharmaceutical Space , அரவிந்தோ பார்மா , தொழிற்சங்கம் மந்திரி சபை ஆன் , ப்ரொடக்ஶந் இணைக்கப்பட்டுள்ளது ஊக்கத்தொகை , அல்கெம் ஆய்வகங்கள் , நீரோடை மருந்து , காடிலா சுகாதாரம் , தொழிற்சங்கம் மந்திரி சபை ,